Suchergebnisse - "Bouattour, Mohamed"

PubPharm (110)

1

Imaging and prognostic characterization of fat-containing hepatocellular carcinoma subtypes

enthalten in: La Radiologia medica | 2024

von Faure, A. | Dioguardi Burgio, M. | Cannella, R. | +8

2

ESR Bridges : imaging and treatment of hepatocellular carcinoma-a multidisciplinary view

enthalten in: European radiology | 2024

von Bouattour, M. | Vilgrain, V. | Sepulveda, A.

3

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

4

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements : A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Parisi, A. | Delaunay, B. | Pinterpe, G. | +42

5

Self-supervised learning to predict intrahepatic cholangiocarcinoma transcriptomic classes on routine histology

enthalten in: bioRxiv.org | 2024

von Beaufrère, A. | Lazard, T. | Nicolle, R. | +14

6

Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma : A matching-adjusted indirect comparison

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Agirrezabal, I. | Bouattour, M. | Pinato, D. | +6

7

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Llovet, J. | Kudo, M. | Merle, P. | +123

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547896

8

Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma : A multicentric retrospective study

enthalten in: United European gastroenterology journal | 2023

von Gigante, E. | Bouattour, M. | Bedoya, J. | +9

9

Plain language summary of the TOPAZ-1 study : durvalumab and chemotherapy for advanced biliary tract cancer

enthalten in: Future oncology (London, England) | 2023

von Oh, D. | He, A. | Qin, S. | +26

ErratumIn: Future Oncol. 2023 Dec 21;:. - PMID 38126178

10

Performances and variability of CT radiomics for the prediction of microvascular invasion and survival in patients with HCC : a matter of chance or standardisation?

enthalten in: European radiology | 2023

von Cannella, R. | Santinha, J. | Bèaufrere, A. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]